The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice

We report that the removal of muscarinic signalling increases T1AM pro learning and hyperalgesic effectiveness suggesting T1AM as a potential treatment as a “pro-drug” for memory dysfunction in neurodegenerative diseases.